Total Payments
$6,570
2024 Payments
$1,204
Companies
42
Transactions
158
Medicare Patients
2,502
Medicare Billing
$404,727
Payment Breakdown by Category
Food & Beverage$5,357 (81.5%)
Travel$1,136 (17.3%)
Education$43.17 (0.7%)
Other$34.17 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,357 | 149 | 81.5% |
| Travel and Lodging | $1,136 | 6 | 17.3% |
| Education | $43.17 | 1 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34.17 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,150 | 8 | $0 (2024) |
| ABBVIE INC. | $794.20 | 32 | $0 (2024) |
| Medtronic USA, Inc. | $726.55 | 5 | $0 (2019) |
| Merz Pharmaceuticals, LLC | $348.67 | 3 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $320.56 | 6 | $0 (2024) |
| Medtronic, Inc. | $276.86 | 3 | $0 (2024) |
| Kyowa Kirin, Inc. | $270.30 | 5 | $0 (2024) |
| Abbott Laboratories | $258.71 | 2 | $0 (2023) |
| Allergan, Inc. | $229.38 | 16 | $0 (2021) |
| GE HealthCare | $170.41 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,204 | 25 | ABBVIE INC. ($341.63) |
| 2023 | $1,143 | 33 | ABBVIE INC. ($204.78) |
| 2022 | $1,549 | 44 | ABBVIE INC. ($247.79) |
| 2021 | $1,026 | 40 | Allergan, Inc. ($184.97) |
| 2020 | $122.64 | 6 | Allergan, Inc. ($44.41) |
| 2019 | $1,526 | 10 | Boston Scientific Corporation ($799.41) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $124.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Neurology | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Neurology | ||||||
| 07/01/2024 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $77.13 | General |
| 06/26/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Neurology | ||||||
| 06/21/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Immunology | ||||||
| 06/11/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $48.97 | General |
| Category: Neurology | ||||||
| 05/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Neurology | ||||||
| 03/27/2024 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $83.43 | General |
| 03/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/02/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $131.44 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 03/02/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $77.27 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 03/02/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $68.15 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 02/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/21/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $138.37 | General |
| Category: Vercise_NMD | ||||||
| 02/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/24/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $62.64 | General |
| Category: Adenosine A2A Receptors | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 879 | 6,539 | $448,063 | $152,050 |
| 2022 | 10 | 788 | 1,130 | $344,719 | $126,040 |
| 2021 | 8 | 606 | 811 | $272,636 | $104,935 |
| 2020 | 7 | 229 | 262 | $90,172 | $21,702 |
Total Patients
2,502
Total Services
8,742
Medicare Billing
$404,727
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 302 | 534 | $154,193 | $53,558 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 139 | 189 | $73,427 | $25,994 | 35.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 19 | 5,325 | $65,495 | $24,333 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $52,729 | $15,599 | 29.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 75 | 75 | $41,580 | $12,921 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 153 | $29,223 | $10,878 | 37.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $8,496 | $2,493 | 29.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,668 | $1,381 | 29.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 11 | 22 | $4,739 | $1,371 | 28.9% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 11 | 22 | $3,846 | $1,143 | 29.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $4,158 | $944.48 | 22.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 12 | 26 | $3,624 | $901.28 | 24.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 18 | 21 | $1,885 | $533.30 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 443 | $121,825 | $46,401 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 170 | 248 | $91,760 | $35,367 | 38.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 81 | 81 | $42,768 | $13,954 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 94 | 94 | $39,668 | $12,609 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 116 | $21,808 | $8,944 | 41.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $6,975 | $2,238 | 32.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 28 | $5,040 | $1,771 | 35.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 19 | 19 | $4,831 | $1,702 | 35.2% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 11 | 30 | $3,983 | $1,276 | 32.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 29 | 35 | $2,993 | $950.78 | 31.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 11 | 11 | $3,069 | $827.67 | 27.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 174 | 310 | $116,684 | $48,084 | 41.2% |
About Dr. Hannah Irving, MD
Dr. Hannah Irving, MD is a Neurology healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2014. The National Provider Identifier (NPI) number assigned to this provider is 1609293562.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hannah Irving, MD has received a total of $6,570 in payments from pharmaceutical and medical device companies, with $1,204 received in 2024. These payments were reported across 158 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,357).
As a Medicare-enrolled provider, Irving has provided services to 2,502 Medicare beneficiaries, totaling 8,742 services with total Medicare billing of $404,727. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Psychiatry, Neurology
- Location Fairfax, VA
- Active Since 03/27/2014
- Last Updated 08/14/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1609293562
Products in Payments
- GENERAL DBS (Device) $773.41
- BOTOX (Biological) $741.55
- ACTIVA (Device) $726.55
- Xeomin (Biological) $348.67
- PERCEPT PC BRAINSENSE (Device) $276.86
- NOURIANZ (Drug) $166.38
- Exablate (Device) $164.12
- VYALEV (Drug) $147.74
- Vercise (Device) $138.37
- INFINITY (Device) $131.09
- Infinity DBS Pulse Generators (Device) $127.62
- GENERAL - DBS (Device) $117.67
- QULIPTA (Drug) $115.03
- Nourianz (Drug) $103.92
- Briviact (Drug) $100.27
- NUPLAZID (Drug) $94.29
- Leqembi (Drug) $85.73
- VYEPTI (Biological) $80.77
- ADUHELM (Biological) $74.33
- AUSTEDO (Drug) $72.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fairfax
Dr. Rahul Dave, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $405,192
Neurology $405,192
John Rothrock, Md, MD
Neurology — Payments: $347,072
Neurology $347,072
Laura Cinski, M.d, M.D
Neurology — Payments: $70,544
Neurology $70,544
Abigail Lawler, M.d, M.D
Neurology — Payments: $45,925
Neurology $45,925
Dr. David Whitney, M.d, M.D
Neurology — Payments: $35,830
Neurology $35,830
Dr. Amy Safadi, Md, MD
Neurology — Payments: $22,090
Neurology $22,090